Use of EC-SOD for treating angiogenesis-mediated eye diseases
- 专利权人:
- 发明人:
- Dong Heon Shin,Tae Yoon Kim
- 申请号：
- US14325107
- 公开号：
- US09089564B2
- 申请日:
- 2014.07.07
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- A method for treating an angiogenesis-mediated eye disease, includes administering to a subject in need thereof an effective amount of EC-SOD protein, or a vector having a polynucleotide encoding the EC-SOD protein, to treat angiogenesis-mediated eye diseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Recombinant adeno-associated virus vectors encoding acid beta glucosidase for use in treating gaucher disease
- Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
- Vector(s) containing an inducible gene encoding a CDK4/CDK6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle
- Vector(S) Containing an Inducible Gene Encoding a CDK4/CDK6 Inhibitor Useful for Treating Neurodegenerative Disorders or Diseases Associated with an Unscheduled Activation of the Cell Cycle
- VECTOR(S) CONTAINING AN INDUCIBLE GENE ENCODING A CDK4/CDK6 INHIBITOR USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS OR DISEASES ASSOCIATED WITH AN UNSCHEDULED ACTIVATION OF THE CELL CYCLE
